rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Patrick J. Mahaffy

Director

Company insider

Files Form 4 as: Director, Medicus Pharma; President and CEO, Clovis Oncology; Director, Flexion Therapeutics; Director, Orexigen Therapeutics; CEO, President, Pharmion.

Every Form 4 they filed

In numbers

Trades disclosed
107
Buys
3
Sells
0
Bought
$899K
Sold
$0
Companies
5
Companies where not an officer
3
First trade
2 Mar 2006
Last trade
3 Jun 2026
Last filed
4 Jun 2026

Companies traded

Where they are an officer
Clovis OncologyDirector, Officer · last 1 Mar 20222 buys · 0 sells
PharmionDirector, Officer · last 7 Mar 20081 buy · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MDCX Medicus PharmaDirector · Biotechnology · last 3 Jun 20260 buys · 0 sells
Flexion TherapeuticsDirector · last 19 Nov 20210 buys · 0 sells
Orexigen TherapeuticsDirector · last 14 Jul 20170 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Jun 2026filed 4 Jun 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
3 Jun 2026filed 4 Jun 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
30 Mar 2026filed 1 Apr 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
30 Mar 2026filed 1 Apr 2026MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
16 Dec 2025filed 18 Dec 2025MDCX Medicus Pharmaoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
1 Mar 2022filed 3 Mar 2022Clovis Oncologyoption or derivativeSEC FORM 4 Code A—220,000 at $0.00filing
1 Mar 2022filed 3 Mar 2022Clovis Oncologyoption or derivativeSEC FORM 4 Code A—80,000 at $0.00filing
1 Mar 2022filed 3 Mar 2022Clovis Oncologyoption or derivativeSEC FORM 4 Code A—80,000 at $0.00filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—18,000filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—12,500filing
19 Nov 2021filed 19 Nov 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code D—12,500filing
19 Nov 2021filed 19 Nov 2021Flexion TherapeuticsSEC FORM 4 Code D$339K39,824 at $8.50filing
24 Jun 2021filed 28 Jun 2021Flexion Therapeuticsoption or derivativeSEC FORM 4 Code A—12,500 at $0.00filing
24 Jun 2021filed 28 Jun 2021Flexion TherapeuticsSEC FORM 4 Code A—4,500 at $0.00filing
1 Mar 2021filed 3 Mar 2021Clovis Oncologyoption or derivativeSEC FORM 4 Code A—220,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.